Skip to content

Influence of alveolar tampon packing on incidence of pain and quality of life in the week following third molar surgery

Influence of alveolar tampon packing on incidence of pain and quality of life in the week following third molar surgery - M3TAMPspQoL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43633
Enrollment
66
Registered
2016-03-09
Start date
2016-04-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dental extractions, post-interventional recovery M3 extraction removal of mandibular wisdom teeth

Interventions

After surgical removal of the mandibular third molar, the patients will receive on one side postoperative treatment with a tampon and the contralateral side will be treated without a tampon (or vice

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients referred to the Department of Oral & Maxillofacial Surgery of the Amstelland Hospital (Ziekenhuis Amstelland) for extraction of only impacted mandibular M3 requiring an ostectomy - Patients who are going to have bilateral mandibular M3 surgery - Patients without previous history of oral disease, free of periodontal disease, no discernable active pathology associated with the M3, and without acute pericoronitis - Patients that signed an informed consent form - Patients >=18 years of age

Exclusion criteria

Exclusion criteria: - Patients with a previous history of periodontal disease or local pathology (e.g. cysts or tumors) associated with the M3s - Patients with ibuprofen allergy - Patients with iodine allergy - Patients with known medical history of renal failure, blood dyscrasia or chronic liver disease of any type, uncontrolled diabetes mellitus, HIV infection, - Patients with a history of recent and/or symptomatic peptic ulcer - Patients on anticoagulants or corticosteroids prior (

Design outcomes

Primary

MeasureTime frame
Postoperative pain measurements (VAS scores, 11-points NRS) and quality of life (QoL) evaluations with OHIP-14 questionnaires.

Secondary

MeasureTime frame
Postoperative infection and alveolaire osteitis (AO).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)